PMID: 26747May 1, 1978

How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?

The Journal of Pharmacy and Pharmacology
D MacKay

Abstract

No abstract listed.

References

Aug 1, 1974·The Journal of Pharmacy and Pharmacology·D Mackay, J Wheeler
Sep 1, 1969·British Journal of Pharmacology·F B AbramsonR P Stephenson
Mar 1, 1959·British Journal of Pharmacology and Chemotherapy·O ARUNLAKSHANA, H O SCHILD
Sep 1, 1947·British Journal of Pharmacology and Chemotherapy·H O SCHILD

Citations

Jan 1, 1991·Cardiovascular Drugs and Therapy·W J LouisL H Tung
Aug 1, 1991·Naunyn-Schmiedeberg's Archives of Pharmacology·Terry Kenakin, C Boselli
Dec 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·J M MayK P Minneman
Jun 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·S M YuC M Teng
Aug 1, 1990·Cardiovascular Drugs and Therapy·H NaritaR Ginsburg
Jun 1, 1990·Cardiovascular Drugs and Therapy·H Narita, R Ginsburg
Jan 1, 1984·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·C J SchmittN N Share
Aug 13, 1982·European Journal of Pharmacology·R SabanS de Moraes
Jul 2, 1987·European Journal of Pharmacology·I P BerzeteiS P Duckles
Mar 3, 1987·European Journal of Pharmacology·A W FoxP W Abel
Jul 14, 1988·European Journal of Pharmacology·I P BerzeteiS P Duckles
Jun 21, 1990·European Journal of Pharmacology·S A DarrochF Mitchelson
Dec 7, 1993·European Journal of Pharmacology·A F RoffelJ Zaagsma
Sep 1, 1994·European Journal of Pharmacology·K H Buchheit, T Buhl
Jul 4, 1996·European Journal of Pharmacology·N H JurkiewiczA Jurkiewicz
Aug 15, 1996·European Journal of Pharmacology·R A Borman, D E Burleigh
Jan 1, 1991·Life Sciences·J J ShenM S Roberts
Jan 1, 1981·Journal of Pharmacological Methods·L OttJ Woodward
Jan 1, 1993·General Pharmacology·J L Lamas, R C Spadari
Feb 9, 2002·European Journal of Pharmacology·Kiyoto Sakata, M Bäck
Jun 18, 2002·European Journal of Pharmacology·Shih-Chieh ChuehChe-Ming Teng
Oct 24, 1996·European Journal of Pharmacology·M R BudhooJ M Kellum
Nov 26, 1997·European Journal of Pharmacology·C BoselliE Grana
Mar 17, 1999·European Journal of Pharmacology·Simon N LouisW J Louis
Feb 23, 2002·European Journal of Medicinal Chemistry·Simon N LouisWilliam J Louis
Mar 11, 1999·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·R XuM L Go
Oct 18, 2000·Journal of Pharmacological and Toxicological Methods·S L ArmourW J Chen
Apr 29, 1998·British Journal of Pharmacology·S LäerJ Neumann
Mar 10, 2001·Clinical and Experimental Pharmacology & Physiology·A Christopoulos
Jul 1, 1985·Clinical and Experimental Pharmacology & Physiology·B Waldeck, E Widmark
Sep 1, 1990·Clinical and Experimental Pharmacology & Physiology·L K Choo, F Mitchelson
Jan 1, 1991·Fundamental & Clinical Pharmacology·K Vidal-Beretervide
Dec 1, 1989·British Journal of Pharmacology·C Hollenga, J Zaagsma
Apr 1, 1992·British Journal of Pharmacology·S E Webber, M J Stock
May 1, 1993·British Journal of Pharmacology·J GarssenF P Nijkamp
Nov 1, 1993·British Journal of Pharmacology·F LonnqvistP Arner
Jun 1, 1994·British Journal of Pharmacology·A MacDonaldD P McLaughlin
Feb 1, 1996·British Journal of Pharmacology·A J HoeyM N Sillence
Oct 1, 1996·British Journal of Pharmacology·A J HoeyM N Sillence
Oct 1, 1992·Pharmacology & Toxicology·A B JeppssonB Waldeck
Jun 1, 1979·The Journal of Pharmacy and Pharmacology·J P Huidobro-ToroM Ruiz
Nov 1, 1993·The Journal of Pharmacy and Pharmacology·S I Sharif
Jan 1, 1996·The Journal of Pharmacy and Pharmacology·M H YenJ W Chern
Feb 18, 1998·The Journal of Pharmacy and Pharmacology·C H LiaoC M Teng
Jan 1, 1997·The Journal of Pharmacy and Pharmacology·M J RamirezB Lasheras
Mar 1, 1992·American Journal of Respiratory Cell and Molecular Biology·V K MaheshJ W Bloom
Sep 1, 2000·Journal of Molecular and Cellular Cardiology·S Lu, A Hoey
Sep 1, 1982·Journal of Pharmacological Methods·D M Gross, D Weitz
Jan 1, 1991·General Pharmacology·R C Spadari, S de Moraes
Oct 13, 2004·British Journal of Pharmacology·Majid SheykhzadeLars Edvinsson
Jun 16, 2004·Vascular Pharmacology·Anja Hviid SimonsenNiels C Berg Nyborg
Jul 15, 1994·Thrombosis Research·A J NicholsJ M Samanen
Jan 13, 2011·Journal of Enzyme Inhibition and Medicinal Chemistry·Radhakrishnan MaheshShushil Kumar Yadav
Mar 16, 2013·Journal of Young Pharmacists : JYP·Radhakrishnan MaheshDk Pandey
Mar 1, 2006·Bioorganic & Medicinal Chemistry Letters·Ramachandran Venkatesha Perumal, Radhakrishnan Mahesh
Sep 1, 1988·Journal of Autonomic Pharmacology·K Vidal-Beretervide, L Castañeda
Sep 1, 1988·Journal of Autonomic Pharmacology·L K ChooP Napier
Sep 1, 2008·Current Protocols in Pharmacology·Terry Kenakin
May 1, 1994·Circulation Research·T A BruningP A van Zwieten
Aug 2, 2006·Autonomic & Autacoid Pharmacology·A M HamrouniK J Broadley
Jan 4, 2007·Autonomic & Autacoid Pharmacology·S O Awe, A S O Adeagbo
Jan 1, 1988·Fundamental & Clinical Pharmacology·K Vidal-Beretervide
Sep 15, 2005·The Journal of Pharmacology and Experimental Therapeutics·Maura FloreaniPaola Dorigo
Sep 1, 1984·The Journal of Pharmacy and Pharmacology·P F Grassby, K J Broadley
Feb 1, 1986·The Journal of Pharmacy and Pharmacology·S NakamuraS I Rajfer
Sep 1, 1980·The Journal of Pharmacy and Pharmacology·U Johansson, B Waldeck

Related Concepts

Drug Antagonism
Pharmaceutical Preparations
Mathematics
Receptors, Drug

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Synthetic Genetic Array Analysis

Synthetic genetic arrays allow the systematic examination of genetic interactions. Here is the latest research focusing on synthetic genetic arrays and their analyses.

Congenital Hyperinsulinism

Congenital hyperinsulinism is caused by genetic mutations resulting in excess insulin secretion from beta cells of the pancreas. Here is the latest research.

Neural Activity: Imaging

Imaging of neural activity in vivo has developed rapidly recently with the advancement of fluorescence microscopy, including new applications using miniaturized microscopes (miniscopes). This feed follows the progress in this growing field.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Epigenetic Memory

Epigenetic memory refers to the heritable genetic changes that are not explained by the DNA sequence. Find the latest research on epigenetic memory here.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Femoral Neoplasms

Femoral Neoplasms are bone tumors that arise in the femur. Discover the latest research on femoral neoplasms here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Related Papers

British Journal of Pharmacology and Chemotherapy
O ARUNLAKSHANA, H O SCHILD
Current Topics in Medicinal Chemistry
Terry Kenakin
© 2021 Meta ULC. All rights reserved